IDT Biologika Establishes New Corporation in the United States

03-Jun-2009 - USA

IDT Biologika announced it has opened new offices outside Washington, DC in Herndon, VA to better serve pharmaceutical and biopharmaceutical customers in the United States. According to the company, the move comes in response to expanding business by IDT Biologika with multinational firms and increased demand for the company’s fully-integrated services in the U.S. market. IDT Biologika’s expanded footprint in the Unites States market coincides with the opening of new filling and packaging facilities in Germany this past January.

According to Dr. Ralf Pfirmann, CEO of IDT Biologika, the establishment of operations in the United States will allow the company to support its customers´ operations in the important U.S. drug market and to develop closer working relationships with firms in the region.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances